Company / Revenue per Share
Gossamer Bio, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.21
FY2025
5-year range
$0.00 / $0.51
FY2022-FY2025
Trend
-58.0%
vs FY2024
Sector context
#127 of 154
Health Care
What the data says
Gossamer Bio, Inc.'s revenue per share of $0.21 is lower than 82% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.21 over the past 2 years.
Based on SEC 10-K filings.
0.21 in FY2025.
Improved from $0.00 to $0.21 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 154This company $0.21 Sector average $15.09
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 58.0% year-over-year.
- Ranks #127 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -58.0% |
| FY2024 | $0.51 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026